| 产品详情 |
| Edit |   |
| Product Name | Concanamycin B |
| Description | Purity >95%. Concanamycin B is a macrolide antibiotic that selectively inhibits vacuolar type H+ -ATPases, also known as V-ATPases (IC50 = 5 nM). In this way, it blocks the acidification of vacuolar organelles as well as early to late endosomal transport. Concanamycin B interferes with bone resorption and maturation of CD8 T lymphocytes. It also prevents processing of major histocompatibility complex (MHC) class II precursors in human B cells, inhibiting the expression of MHC class II molecules on the cell surface. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[[4-O-(aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-8,10-dihydroxy-3,17-dimethox, 8-deethyl-8-methyl-Concanamycin A, MCH 210 |
| Gene, Accession, CAS # | CAS: 81552-33-2 |
| Catalog # | LS-H7229 |
| Price | |
| Order / More Info | Concanamycin B from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|